查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球运动病治疗市场规模、份额和行业趋势分析报告：按药物类别（抗组胺药、抗胆碱能药、其他）、给药途径、分销渠道、地区展望和预测，2023-2029 年
市场调查报告书
商品编码
1276453

全球运动病治疗市场规模、份额和行业趋势分析报告：按药物类别（抗组胺药、抗胆碱能药、其他）、给药途径、分销渠道、地区展望和预测，2023-2029 年

Global Motion Sickness Treatment Market Size, Share & Industry Trends Analysis Report By Drug Class (Antihistamines, Anticholinergics and Others), By Route of Administration, By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2029
出版日期: | 出版商: KBV Research | 英文 203 Pages | 订单完成后即时交付

价格

晕动病治疗市场规模预计到 2029 年将达到 4.81 亿美元，在预测期内以 3.2% 的复合年增长率增长。

晕车可能会意外发生。 可能会出现因体温突然下降而出汗等症状，恕不另行通知。 头晕、乏力、头痛、烦躁、注意力不集中。 它还会导致肠胃不适和麵色苍白。 呼吸困难的症状可能包括呼吸急促和喘息。

COVID-19 影响分析

在 COVID-19 疫情期间，全球旅游和旅行的数量减少，晕车药的销量也随之下降。 结果，晕车治疗市场受到了很大影响。 大流行还导致全球大多数工业部门的生产活动停止或中断。 这也对晕车药的生产产生了一定的影响。 在医疗保健行业，COVID-19 大流行扰乱了工作流程。

市场增长因素

旅游业的增长

由于机票价格下降、前往偏远而美丽的旅游目的地的交通便利以及可支配收入激增，旅游业正在发展。 交通和基础设施的重大发展推动了旅游业的发展。 千禧一代旅行者越来越需要独特和专属的体验，而生态旅游是当前情况下的增长趋势。 世界几乎每个地方的国内和国际游客都在增加，个人使用飞机、汽车和轮船等不同类型的交通工具到达目的地。 然而，这些交通方式可能会导致许多旅行者晕车，并可能需要治疗，从而推动了市场的增长。

不断发展的製药行业寻求加强晕动病治疗

随着创新技术的引入和製造流程的简化，製药行业正在发生重大变化，以使其具有成本效益和效率。 此外，该部门不断增加的投资流量对该部门的增长产生了积极影响。 机器人技术和人工智能的集成可以减少製造车间的停机时间并最大限度地减少产品浪费。 製药行业的发展及其技术进步有望提供更高效、更具成本效益的晕车治疗药物，从而增加其采用率并推动晕车治疗市场的增长。

市场製约因素

与晕车药相关的副作用

某些职业（例如宇航员）会限制 H1 抗组胺药的使用，因为它会影响认知功能、记忆力、心理运动表现、嗜睡、疲劳和头晕。 此外，肌张力障碍、运动障碍、烦躁不安、定向障碍、妄想和对心臟的潜在危害也有报导。 此外，第一代抗组胺药的抗胆碱能作用可导致副作用，包括但不限于口干、视力模糊、瞳孔散大和尿潴留。 因此，抗组胺药和抗胆碱能药这两种治疗晕动病最突出的药物类别的副作用很可能会减少这些疗法的采用，从而阻碍晕动病治疗市场的增长。

药物类别展望

晕动病治疗市场根据药物类别分为抗组胺药、抗胆碱能药等。 抗组胺药细分市场在 2022 年的收入份额最大的晕动病治疗市场占据主导地位。 这是因为抗组胺药是一种具有成本效益且易于获得的减少晕动病的解决方案。 这是由于旅行者晕车的患病率上升。 此外，为预防和治疗晕动病提供抗组胺药的领先公司的存在也推动了这一细分市场的增长。

管理路线展望

晕动病治疗市场按给药途径分为口服药物和非口服药物。 到 2022 年，非口服部分在晕动病治疗市场中占据了很大的收入份额。 这是由于越来越多地使用透皮贴剂来治疗和预防晕动病。 此外，与传统药物相比，这些透皮贴剂具有易用性、控释机制和延长疗效等优势。

按分销渠道划分的前景

按分销渠道，晕动病治疗市场分为药店和零售药店、网上药店和医院药店。 2022 年，药店和零售药店在晕动病治疗市场的收入份额最大。 这是因为药房和药店一直是向消费者分发晕车药的传统方式。 这些机构以折扣价提供这些产品。 药店和零售药店是很多人购买晕车药的首选。

区域展望

分析了以下地区的晕动病治疗市场：北美、欧洲、亚太地区和 LAMEA（拉丁美洲、中东和非洲）。 到 2022 年，北美地区将占据晕动病治疗市场的最高收入份额。 北美在医疗保健行业的主导地位归功于其发达的医疗保健基础设施和政府对优质医疗保健的支持。 因此，北美有许多知名的市场参与者提供一流的晕车药。

该报告涵盖了对市场主要利益相关者的分析。 本报告介绍的主要公司有 Viatris, Inc.、Teva Pharmaceutical Industries Ltd.、Amneal Pharmaceuticals, Inc.、Baxter International, Inc.、Novartis AG、Abbott Laboratories、Sun Pharmaceutical Industries Ltd.、Zydus Lifesciences Ltd.、Prestige Consumer Healthcare , Inc., WellSpring Pharmaceutical Corporation (Avista Capital Partners)。

内容

第一章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场范围
  • 细分
    • 全球运动病治疗市场：按药物分类
    • 全球运动病治疗市场：按给药途径分类
    • 全球运动病治疗市场：按分销渠道
    • 全球运动病治疗市场：按地区
  • 调查方法

第 2 章市场概述

  • 简介
    • 概览
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场製约因素

第 3 章全球运动病治疗市场：按药物类别分类

  • 全球抗组胺药市场：按地区
  • 全球抗胆碱药市场：按地区
  • 按地区划分的剩余全球市场

第 4 章全球运动病治疗市场：按给药途径

  • 全球口服药市场：按地区
  • 按地区划分的剩余全球市场

第 5 章全球运动病治疗市场：按分销渠道

  • 全球药店和零售药店市场，按地区
  • 全球医院药房市场：按地区
  • 全球在线药店市场：按地区

第 6 章全球运动病治疗市场：按地区

  • 北美
    • 北美市场：按国家/地区分类
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 欧洲市场：按国家/地区分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲地区
  • 亚太地区
    • 亚太市场：按国家/地区分类
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • LAMEA（拉丁美洲/中东/非洲）
    • LAMEA 市场：按国家/地区分类
      • 巴西
      • 阿根廷
      • 阿拉伯联合酋长国
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 拉美其他地区

第七章公司简介

  • Viatris, Inc
  • Teva Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals, Inc
  • Baxter International, Inc
  • Novartis AG
  • Abbott Laboratories
  • Sun Pharmaceutical Industries Ltd
  • Zydus Lifesciences Ltd
  • Prestige Consumer Healthcare, Inc
  • WellSpring Pharmaceutical Corporation（Avista Capital Partners）

The Global Motion Sickness Treatment Market size is expected to reach $481 Million by 2029, rising at a market growth of 3.2% CAGR during the forecast period.

Motion sickness is a condition that arises when the brain is unable to interpret the information received from the eyes, ears, and body. Frequent movement, whether in a vehicle, aircraft, watercraft, or a recreational attraction, can induce discomfort, perspiration, or nausea. Certain individuals experience nausea and may regurgitate. Motion sickness is a condition that occurs when traveling by car, sea, or air, causing discomfort and nausea.

When driving a vehicle, the visual senses perceive the surroundings and detect motion. The inner ears are responsible for detecting movement. The body's muscles and joints perceive a state of stillness while seated. The brain senses a lack of coherence between these messages, causing motion sickness. Various factors can induce motion sickness, including amusement park attractions and virtual reality simulations. Reading while in transit, using transportation options like boats, cars, buses, trains, and planes. Also, too much consumption of entertainment media such as movies and video games can lead to motion sickness.

Motion sickness may occur unexpectedly. Individuals may exhibit symptoms without prior warning, including perspiration caused by a sudden drop in body temperature. Dizziness, fatigue, headache, irritability, difficulty in maintaining focus. Symptoms of potential gastrointestinal distress. Fair complexion. Symptoms of respiratory distress may include rapid breathing or gasping for air.

COVID-19 Impact Analysis

During the COVID-19 pandemic, the number of tours and journeys throughout the world declined, which led to a subsequent drop in sales of motion sickness medication. As a result, the market for motion sickness therapy was significantly damaged. In addition, the pandemic was responsible for the shutdown or suspension of production operations in most industrial units around the world. This had an effect, to some degree, on the production of motion sickness treatments. The healthcare industry has experienced a disruption in workflows due to the COVID-19 pandemic.

Market Growth Factors

Rising Tourism Industry

The travel and tourism industry are increasing due to the increasing affordability of air travel, enhanced accessibility to remote and picturesque destinations, and a surge in disposable income. The travel and tourism sector has been strengthened by the substantial development of transportation facilities and infrastructure. There is a growing demand among millennial travelers for distinctive and exclusive experiences and also ecotourism is a growing trend in the current scenario. National and international tourism is increasing in almost all parts of the world, and individuals use various types of transportation to reach their destinations, like airplanes, cars, and ships. However, these modes of transportation can cause many travelers' motion sickness to kick in, which may require treatment and thereby propel the market growth.

Growing Pharma Sector to Provide Enhanced Motion Sickness Medications

The pharmaceutical industry has experienced significant changes due to the introduction of innovative technologies and streamlined manufacturing processes that are both cost-effective and efficient. Furthermore, the rise in investment flow within this sector has positively impacted sector growth. Integrating robotic technology and AI leads to decreased manufacturing floor downtime and minimizes product waste. The development of the pharma sector and its technological advancement is expected to provide more efficient and cost-effective medications for motion sickness and thereby increase their adoption, driving the market growth for motion sickness treatment.

Market Restraining Factors

Associated Side Effects of Motion Sickness Medication

H1-antihistamines in certain professions, such as astronauts, are limited due to side effects that can affect cognitive function, memory, psychomotor performance, drowsiness, fatigue, and dizziness. Additional documented negative outcomes comprise dystonia, dyskinesia, restlessness, disorientation, delusions, and potential harm to the heart. Furthermore, the anticholinergic activity of first-generation antihistamines may result in adverse effects, including but not limited to dry mouth, blurred vision, dilated pupils, and urinary retention. Hence, with the side effects of antihistamines and anticholinergics two most prominent drug classes for the treatment of motion sickness can decrease the adoption of these treatment options and, thereby, hamper the market growth of motion sickness treatment.

Drug Class Outlook

Based on drug class, the motion sickness treatment market is segmented into antihistamines, anticholinergics and others. The antihistamines segment dominated the motion sickness treatment market with maximum revenue share in 2022. This is because antihistamines are a cost-effective and readily available solution for reducing motion sickness. This is due to a rise in the prevalence of motion sickness among travelers. Furthermore, the segment's growth is being propelled by the presence of major players who provide antihistamine medications to prevent and treat motion sickness.

Route of Administration Outlook

On the basis of route of administration, the motion sickness treatment market is divided into oral and others. The others segment procured a substantial revenue share in the motion sickness treatment market in 2022. This is due to the rise in the usage of transdermal patches for motion sickness treatment and prevention, which is the reason behind this trend. In addition, these transdermal patches provide benefits such as user-friendliness, controlled release mechanism, and extended efficacy in comparison to traditional medications.

Distribution Channel Outlook

By distribution channel, the motion sickness treatment market is classified into drug store & retail pharmacies, online pharmacies and hospital pharmacies. The drug store & retail pharmacies segment witnessed the largest revenue share in the motion sickness treatment market in 2022. This is because pharmacies and drug stores have been the traditional means of distributing motion sickness medication to consumers. These establishments offer these products at discounted prices. Drug stores and retail pharmacies are the preferred choice for purchasing motion sickness medications among most of the population.

Regional Outlook

Region-wise, the motion sickness treatment market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the motion sickness treatment market in 2022. North America's dominant position in the healthcare industry can be attributed to its robust healthcare infrastructure and government backing for high-quality healthcare. As a result, North America has a significant number of prominent market players who provide top-notch motion sickness medications.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Viatris, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG, Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Prestige Consumer Healthcare, Inc., WellSpring Pharmaceutical Corporation (Avista Capital Partners)

Scope of the Study

Market Segments covered in the Report:

By Drug Class

  • Antihistamines
  • Anticholinergics
  • Others

By Route of Administration

  • Oral
  • Others

By Distribution Channel

  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Viatris, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Baxter International, Inc.
  • Novartis AG
  • Abbott Laboratories
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Lifesciences Ltd.
  • Prestige Consumer Healthcare, Inc.
  • WellSpring Pharmaceutical Corporation (Avista Capital Partners)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Motion Sickness Treatment Market, by Drug Class
    • 1.4.2 Global Motion Sickness Treatment Market, by Route of Administration
    • 1.4.3 Global Motion Sickness Treatment Market, by Distribution Channel
    • 1.4.4 Global Motion Sickness Treatment Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Motion Sickness Treatment Market by Drug Class

  • 3.1 Global Antihistamines Market by Region
  • 3.2 Global Anticholinergics Market by Region
  • 3.3 Global Others Market by Region

Chapter 4. Global Motion Sickness Treatment Market by Route of Administration

  • 4.1 Global Oral Market by Region
  • 4.2 Global Others Market by Region

Chapter 5. Global Motion Sickness Treatment Market by Distribution Channel

  • 5.1 Global Drug Store & Retail Pharmacies Market by Region
  • 5.2 Global Hospital Pharmacies Market by Region
  • 5.3 Global Online Pharmacies Market by Region

Chapter 6. Global Motion Sickness Treatment Market by Region

  • 6.1 North America Motion Sickness Treatment Market
    • 6.1.1 North America Motion Sickness Treatment Market by Drug Class
      • 6.1.1.1 North America Antihistamines Market by Country
      • 6.1.1.2 North America Anticholinergics Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Motion Sickness Treatment Market by Route of Administration
      • 6.1.2.1 North America Oral Market by Country
      • 6.1.2.2 North America Others Market by Country
    • 6.1.3 North America Motion Sickness Treatment Market by Distribution Channel
      • 6.1.3.1 North America Drug Store & Retail Pharmacies Market by Country
      • 6.1.3.2 North America Hospital Pharmacies Market by Country
      • 6.1.3.3 North America Online Pharmacies Market by Country
    • 6.1.4 North America Motion Sickness Treatment Market by Country
      • 6.1.4.1 US Motion Sickness Treatment Market
        • 6.1.4.1.1 US Motion Sickness Treatment Market by Drug Class
        • 6.1.4.1.2 US Motion Sickness Treatment Market by Route of Administration
        • 6.1.4.1.3 US Motion Sickness Treatment Market by Distribution Channel
      • 6.1.4.2 Canada Motion Sickness Treatment Market
        • 6.1.4.2.1 Canada Motion Sickness Treatment Market by Drug Class
        • 6.1.4.2.2 Canada Motion Sickness Treatment Market by Route of Administration
        • 6.1.4.2.3 Canada Motion Sickness Treatment Market by Distribution Channel
      • 6.1.4.3 Mexico Motion Sickness Treatment Market
        • 6.1.4.3.1 Mexico Motion Sickness Treatment Market by Drug Class
        • 6.1.4.3.2 Mexico Motion Sickness Treatment Market by Route of Administration
        • 6.1.4.3.3 Mexico Motion Sickness Treatment Market by Distribution Channel
      • 6.1.4.4 Rest of North America Motion Sickness Treatment Market
        • 6.1.4.4.1 Rest of North America Motion Sickness Treatment Market by Drug Class
        • 6.1.4.4.2 Rest of North America Motion Sickness Treatment Market by Route of Administration
        • 6.1.4.4.3 Rest of North America Motion Sickness Treatment Market by Distribution Channel
  • 6.2 Europe Motion Sickness Treatment Market
    • 6.2.1 Europe Motion Sickness Treatment Market by Drug Class
      • 6.2.1.1 Europe Antihistamines Market by Country
      • 6.2.1.2 Europe Anticholinergics Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Motion Sickness Treatment Market by Route of Administration
      • 6.2.2.1 Europe Oral Market by Country
      • 6.2.2.2 Europe Others Market by Country
    • 6.2.3 Europe Motion Sickness Treatment Market by Distribution Channel
      • 6.2.3.1 Europe Drug Store & Retail Pharmacies Market by Country
      • 6.2.3.2 Europe Hospital Pharmacies Market by Country
      • 6.2.3.3 Europe Online Pharmacies Market by Country
    • 6.2.4 Europe Motion Sickness Treatment Market by Country
      • 6.2.4.1 Germany Motion Sickness Treatment Market
        • 6.2.4.1.1 Germany Motion Sickness Treatment Market by Drug Class
        • 6.2.4.1.2 Germany Motion Sickness Treatment Market by Route of Administration
        • 6.2.4.1.3 Germany Motion Sickness Treatment Market by Distribution Channel
      • 6.2.4.2 UK Motion Sickness Treatment Market
        • 6.2.4.2.1 UK Motion Sickness Treatment Market by Drug Class
        • 6.2.4.2.2 UK Motion Sickness Treatment Market by Route of Administration
        • 6.2.4.2.3 UK Motion Sickness Treatment Market by Distribution Channel
      • 6.2.4.3 France Motion Sickness Treatment Market
        • 6.2.4.3.1 France Motion Sickness Treatment Market by Drug Class
        • 6.2.4.3.2 France Motion Sickness Treatment Market by Route of Administration
        • 6.2.4.3.3 France Motion Sickness Treatment Market by Distribution Channel
      • 6.2.4.4 Russia Motion Sickness Treatment Market
        • 6.2.4.4.1 Russia Motion Sickness Treatment Market by Drug Class
        • 6.2.4.4.2 Russia Motion Sickness Treatment Market by Route of Administration
        • 6.2.4.4.3 Russia Motion Sickness Treatment Market by Distribution Channel
      • 6.2.4.5 Spain Motion Sickness Treatment Market
        • 6.2.4.5.1 Spain Motion Sickness Treatment Market by Drug Class
        • 6.2.4.5.2 Spain Motion Sickness Treatment Market by Route of Administration
        • 6.2.4.5.3 Spain Motion Sickness Treatment Market by Distribution Channel
      • 6.2.4.6 Italy Motion Sickness Treatment Market
        • 6.2.4.6.1 Italy Motion Sickness Treatment Market by Drug Class
        • 6.2.4.6.2 Italy Motion Sickness Treatment Market by Route of Administration
        • 6.2.4.6.3 Italy Motion Sickness Treatment Market by Distribution Channel
      • 6.2.4.7 Rest of Europe Motion Sickness Treatment Market
        • 6.2.4.7.1 Rest of Europe Motion Sickness Treatment Market by Drug Class
        • 6.2.4.7.2 Rest of Europe Motion Sickness Treatment Market by Route of Administration
        • 6.2.4.7.3 Rest of Europe Motion Sickness Treatment Market by Distribution Channel
  • 6.3 Asia Pacific Motion Sickness Treatment Market
    • 6.3.1 Asia Pacific Motion Sickness Treatment Market by Drug Class
      • 6.3.1.1 Asia Pacific Antihistamines Market by Country
      • 6.3.1.2 Asia Pacific Anticholinergics Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Motion Sickness Treatment Market by Route of Administration
      • 6.3.2.1 Asia Pacific Oral Market by Country
      • 6.3.2.2 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Motion Sickness Treatment Market by Distribution Channel
      • 6.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
      • 6.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
      • 6.3.3.3 Asia Pacific Online Pharmacies Market by Country
    • 6.3.4 Asia Pacific Motion Sickness Treatment Market by Country
      • 6.3.4.1 China Motion Sickness Treatment Market
        • 6.3.4.1.1 China Motion Sickness Treatment Market by Drug Class
        • 6.3.4.1.2 China Motion Sickness Treatment Market by Route of Administration
        • 6.3.4.1.3 China Motion Sickness Treatment Market by Distribution Channel
      • 6.3.4.2 Japan Motion Sickness Treatment Market
        • 6.3.4.2.1 Japan Motion Sickness Treatment Market by Drug Class
        • 6.3.4.2.2 Japan Motion Sickness Treatment Market by Route of Administration
        • 6.3.4.2.3 Japan Motion Sickness Treatment Market by Distribution Channel
      • 6.3.4.3 India Motion Sickness Treatment Market
        • 6.3.4.3.1 India Motion Sickness Treatment Market by Drug Class
        • 6.3.4.3.2 India Motion Sickness Treatment Market by Route of Administration
        • 6.3.4.3.3 India Motion Sickness Treatment Market by Distribution Channel
      • 6.3.4.4 South Korea Motion Sickness Treatment Market
        • 6.3.4.4.1 South Korea Motion Sickness Treatment Market by Drug Class
        • 6.3.4.4.2 South Korea Motion Sickness Treatment Market by Route of Administration
        • 6.3.4.4.3 South Korea Motion Sickness Treatment Market by Distribution Channel
      • 6.3.4.5 Singapore Motion Sickness Treatment Market
        • 6.3.4.5.1 Singapore Motion Sickness Treatment Market by Drug Class
        • 6.3.4.5.2 Singapore Motion Sickness Treatment Market by Route of Administration
        • 6.3.4.5.3 Singapore Motion Sickness Treatment Market by Distribution Channel
      • 6.3.4.6 Malaysia Motion Sickness Treatment Market
        • 6.3.4.6.1 Malaysia Motion Sickness Treatment Market by Drug Class
        • 6.3.4.6.2 Malaysia Motion Sickness Treatment Market by Route of Administration
        • 6.3.4.6.3 Malaysia Motion Sickness Treatment Market by Distribution Channel
      • 6.3.4.7 Rest of Asia Pacific Motion Sickness Treatment Market
        • 6.3.4.7.1 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class
        • 6.3.4.7.2 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration
        • 6.3.4.7.3 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel
  • 6.4 LAMEA Motion Sickness Treatment Market
    • 6.4.1 LAMEA Motion Sickness Treatment Market by Drug Class
      • 6.4.1.1 LAMEA Antihistamines Market by Country
      • 6.4.1.2 LAMEA Anticholinergics Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Motion Sickness Treatment Market by Route of Administration
      • 6.4.2.1 LAMEA Oral Market by Country
      • 6.4.2.2 LAMEA Others Market by Country
    • 6.4.3 LAMEA Motion Sickness Treatment Market by Distribution Channel
      • 6.4.3.1 LAMEA Drug Store & Retail Pharmacies Market by Country
      • 6.4.3.2 LAMEA Hospital Pharmacies Market by Country
      • 6.4.3.3 LAMEA Online Pharmacies Market by Country
    • 6.4.4 LAMEA Motion Sickness Treatment Market by Country
      • 6.4.4.1 Brazil Motion Sickness Treatment Market
        • 6.4.4.1.1 Brazil Motion Sickness Treatment Market by Drug Class
        • 6.4.4.1.2 Brazil Motion Sickness Treatment Market by Route of Administration
        • 6.4.4.1.3 Brazil Motion Sickness Treatment Market by Distribution Channel
      • 6.4.4.2 Argentina Motion Sickness Treatment Market
        • 6.4.4.2.1 Argentina Motion Sickness Treatment Market by Drug Class
        • 6.4.4.2.2 Argentina Motion Sickness Treatment Market by Route of Administration
        • 6.4.4.2.3 Argentina Motion Sickness Treatment Market by Distribution Channel
      • 6.4.4.3 UAE Motion Sickness Treatment Market
        • 6.4.4.3.1 UAE Motion Sickness Treatment Market by Drug Class
        • 6.4.4.3.2 UAE Motion Sickness Treatment Market by Route of Administration
        • 6.4.4.3.3 UAE Motion Sickness Treatment Market by Distribution Channel
      • 6.4.4.4 Saudi Arabia Motion Sickness Treatment Market
        • 6.4.4.4.1 Saudi Arabia Motion Sickness Treatment Market by Drug Class
        • 6.4.4.4.2 Saudi Arabia Motion Sickness Treatment Market by Route of Administration
        • 6.4.4.4.3 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel
      • 6.4.4.5 South Africa Motion Sickness Treatment Market
        • 6.4.4.5.1 South Africa Motion Sickness Treatment Market by Drug Class
        • 6.4.4.5.2 South Africa Motion Sickness Treatment Market by Route of Administration
        • 6.4.4.5.3 South Africa Motion Sickness Treatment Market by Distribution Channel
      • 6.4.4.6 Nigeria Motion Sickness Treatment Market
        • 6.4.4.6.1 Nigeria Motion Sickness Treatment Market by Drug Class
        • 6.4.4.6.2 Nigeria Motion Sickness Treatment Market by Route of Administration
        • 6.4.4.6.3 Nigeria Motion Sickness Treatment Market by Distribution Channel
      • 6.4.4.7 Rest of LAMEA Motion Sickness Treatment Market
        • 6.4.4.7.1 Rest of LAMEA Motion Sickness Treatment Market by Drug Class
        • 6.4.4.7.2 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration
        • 6.4.4.7.3 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 Viatris, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Teva Pharmaceutical Industries Ltd.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Amneal Pharmaceuticals, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental Analysis
    • 7.3.4 Research & Development Expenses
  • 7.4 Baxter International, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 Novartis AG
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
  • 7.6 Abbott Laboratories
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 SWOT Analysis
  • 7.7 Sun Pharmaceutical Industries Ltd.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional Analysis
    • 7.7.4 Research & Development Expenses
  • 7.8 Zydus Lifesciences Ltd.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Trials and Approvals:
  • 7.9 Prestige Consumer Healthcare, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
  • 7.10. WellSpring Pharmaceutical Corporation (Avista Capital Partners)
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 2 Global Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 3 Global Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 4 Global Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 5 Global Antihistamines Market by Region, 2019 - 2022, USD Million
  • TABLE 6 Global Antihistamines Market by Region, 2023 - 2029, USD Million
  • TABLE 7 Global Anticholinergics Market by Region, 2019 - 2022, USD Million
  • TABLE 8 Global Anticholinergics Market by Region, 2023 - 2029, USD Million
  • TABLE 9 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 10 Global Others Market by Region, 2023 - 2029, USD Million
  • TABLE 11 Global Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 12 Global Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 13 Global Oral Market by Region, 2019 - 2022, USD Million
  • TABLE 14 Global Oral Market by Region, 2023 - 2029, USD Million
  • TABLE 15 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 16 Global Others Market by Region, 2023 - 2029, USD Million
  • TABLE 17 Global Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 18 Global Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 19 Global Drug Store & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 20 Global Drug Store & Retail Pharmacies Market by Region, 2023 - 2029, USD Million
  • TABLE 21 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 22 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
  • TABLE 23 Global Online Pharmacies Market by Region, 2019 - 2022, USD Million
  • TABLE 24 Global Online Pharmacies Market by Region, 2023 - 2029, USD Million
  • TABLE 25 Global Motion Sickness Treatment Market by Region, 2019 - 2022, USD Million
  • TABLE 26 Global Motion Sickness Treatment Market by Region, 2023 - 2029, USD Million
  • TABLE 27 North America Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 28 North America Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 29 North America Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 30 North America Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 31 North America Antihistamines Market by Country, 2019 - 2022, USD Million
  • TABLE 32 North America Antihistamines Market by Country, 2023 - 2029, USD Million
  • TABLE 33 North America Anticholinergics Market by Country, 2019 - 2022, USD Million
  • TABLE 34 North America Anticholinergics Market by Country, 2023 - 2029, USD Million
  • TABLE 35 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 36 North America Others Market by Country, 2023 - 2029, USD Million
  • TABLE 37 North America Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 38 North America Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 39 North America Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 40 North America Oral Market by Country, 2023 - 2029, USD Million
  • TABLE 41 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 42 North America Others Market by Country, 2023 - 2029, USD Million
  • TABLE 43 North America Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 44 North America Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 45 North America Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 46 North America Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 47 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 48 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 49 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 50 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 51 North America Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
  • TABLE 52 North America Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
  • TABLE 53 US Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 54 US Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 55 US Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 56 US Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 57 US Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 58 US Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 59 US Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 60 US Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 61 Canada Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 62 Canada Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 63 Canada Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 64 Canada Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 65 Canada Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 66 Canada Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 67 Canada Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 68 Canada Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 69 Mexico Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 70 Mexico Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 71 Mexico Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 72 Mexico Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 73 Mexico Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 74 Mexico Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 75 Mexico Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 76 Mexico Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 77 Rest of North America Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 78 Rest of North America Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 79 Rest of North America Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 80 Rest of North America Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 81 Rest of North America Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 82 Rest of North America Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 83 Rest of North America Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 84 Rest of North America Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 85 Europe Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 86 Europe Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 87 Europe Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 88 Europe Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 89 Europe Antihistamines Market by Country, 2019 - 2022, USD Million
  • TABLE 90 Europe Antihistamines Market by Country, 2023 - 2029, USD Million
  • TABLE 91 Europe Anticholinergics Market by Country, 2019 - 2022, USD Million
  • TABLE 92 Europe Anticholinergics Market by Country, 2023 - 2029, USD Million
  • TABLE 93 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 94 Europe Others Market by Country, 2023 - 2029, USD Million
  • TABLE 95 Europe Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 96 Europe Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 97 Europe Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 98 Europe Oral Market by Country, 2023 - 2029, USD Million
  • TABLE 99 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 100 Europe Others Market by Country, 2023 - 2029, USD Million
  • TABLE 101 Europe Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 102 Europe Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 103 Europe Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 104 Europe Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 105 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 106 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 107 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 108 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 109 Europe Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
  • TABLE 111 Germany Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 112 Germany Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 113 Germany Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 114 Germany Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 115 Germany Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 116 Germany Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 117 Germany Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 118 Germany Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 119 UK Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 120 UK Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 121 UK Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 122 UK Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 123 UK Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 124 UK Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 125 UK Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 126 UK Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 127 France Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 128 France Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 129 France Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 130 France Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 131 France Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 132 France Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 133 France Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 134 France Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 135 Russia Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 136 Russia Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 137 Russia Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 138 Russia Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 139 Russia Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 140 Russia Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 141 Russia Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 142 Russia Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 143 Spain Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 144 Spain Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 145 Spain Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 146 Spain Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 147 Spain Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 148 Spain Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 149 Spain Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 150 Spain Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 151 Italy Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 152 Italy Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 153 Italy Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 154 Italy Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 155 Italy Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 156 Italy Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 157 Italy Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 158 Italy Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 159 Rest of Europe Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 160 Rest of Europe Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 161 Rest of Europe Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 162 Rest of Europe Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 163 Rest of Europe Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 164 Rest of Europe Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 165 Rest of Europe Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 166 Rest of Europe Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 167 Asia Pacific Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 168 Asia Pacific Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 169 Asia Pacific Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 170 Asia Pacific Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 171 Asia Pacific Antihistamines Market by Country, 2019 - 2022, USD Million
  • TABLE 172 Asia Pacific Antihistamines Market by Country, 2023 - 2029, USD Million
  • TABLE 173 Asia Pacific Anticholinergics Market by Country, 2019 - 2022, USD Million
  • TABLE 174 Asia Pacific Anticholinergics Market by Country, 2023 - 2029, USD Million
  • TABLE 175 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 176 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
  • TABLE 177 Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 178 Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 179 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 180 Asia Pacific Oral Market by Country, 2023 - 2029, USD Million
  • TABLE 181 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 182 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
  • TABLE 183 Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 184 Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 185 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 186 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 187 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 188 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 189 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 190 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 191 Asia Pacific Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
  • TABLE 192 Asia Pacific Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
  • TABLE 193 China Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 194 China Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 195 China Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 196 China Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 197 China Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 198 China Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 199 China Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 200 China Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 201 Japan Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 202 Japan Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 203 Japan Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 204 Japan Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 205 Japan Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 206 Japan Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 207 Japan Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 208 Japan Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 209 India Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 210 India Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 211 India Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 212 India Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 213 India Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 214 India Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 215 India Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 216 India Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 217 South Korea Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 218 South Korea Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 219 South Korea Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 220 South Korea Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 221 South Korea Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 222 South Korea Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 223 South Korea Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 224 South Korea Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 225 Singapore Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 226 Singapore Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 227 Singapore Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 228 Singapore Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 229 Singapore Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 230 Singapore Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 231 Singapore Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 232 Singapore Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 233 Malaysia Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 234 Malaysia Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 235 Malaysia Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 236 Malaysia Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 237 Malaysia Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 238 Malaysia Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 239 Malaysia Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 240 Malaysia Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 241 Rest of Asia Pacific Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 242 Rest of Asia Pacific Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 243 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 244 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 245 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 246 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 247 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 248 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 249 LAMEA Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 250 LAMEA Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 251 LAMEA Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 252 LAMEA Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 253 LAMEA Antihistamines Market by Country, 2019 - 2022, USD Million
  • TABLE 254 LAMEA Antihistamines Market by Country, 2023 - 2029, USD Million
  • TABLE 255 LAMEA Anticholinergics Market by Country, 2019 - 2022, USD Million
  • TABLE 256 LAMEA Anticholinergics Market by Country, 2023 - 2029, USD Million
  • TABLE 257 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 258 LAMEA Others Market by Country, 2023 - 2029, USD Million
  • TABLE 259 LAMEA Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 260 LAMEA Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 261 LAMEA Oral Market by Country, 2019 - 2022, USD Million
  • TABLE 262 LAMEA Oral Market by Country, 2023 - 2029, USD Million
  • TABLE 263 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 264 LAMEA Others Market by Country, 2023 - 2029, USD Million
  • TABLE 265 LAMEA Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 266 LAMEA Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 267 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 268 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 269 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 270 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 271 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 272 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
  • TABLE 273 LAMEA Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
  • TABLE 274 LAMEA Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
  • TABLE 275 Brazil Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 276 Brazil Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 277 Brazil Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 278 Brazil Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 279 Brazil Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 280 Brazil Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 281 Brazil Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 282 Brazil Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 283 Argentina Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 284 Argentina Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 285 Argentina Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 286 Argentina Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 287 Argentina Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 288 Argentina Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 289 Argentina Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 290 Argentina Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 291 UAE Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 292 UAE Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 293 UAE Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 294 UAE Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 295 UAE Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 296 UAE Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 297 UAE Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 298 UAE Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 299 Saudi Arabia Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 300 Saudi Arabia Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 301 Saudi Arabia Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 302 Saudi Arabia Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 303 Saudi Arabia Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 304 Saudi Arabia Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 305 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 306 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 307 South Africa Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 308 South Africa Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 309 South Africa Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 310 South Africa Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 311 South Africa Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 312 South Africa Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 313 South Africa Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 314 South Africa Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 315 Nigeria Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 316 Nigeria Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 317 Nigeria Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 318 Nigeria Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 319 Nigeria Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 320 Nigeria Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 321 Nigeria Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 322 Nigeria Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 323 Rest of LAMEA Motion Sickness Treatment Market, 2019 - 2022, USD Million
  • TABLE 324 Rest of LAMEA Motion Sickness Treatment Market, 2023 - 2029, USD Million
  • TABLE 325 Rest of LAMEA Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
  • TABLE 326 Rest of LAMEA Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
  • TABLE 327 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
  • TABLE 328 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
  • TABLE 329 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 330 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
  • TABLE 331 key information - Viatris, Inc.
  • TABLE 332 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 333 Key Information - Amneal Pharmaceuticals, INc.
  • TABLE 334 Key Information - Baxter International, Inc.
  • TABLE 335 Key Information - Novartis AG
  • TABLE 336 Key Information - Abbott Laboratories
  • TABLE 337 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 338 Key Information - Zydus Lifesciences Ltd.
  • TABLE 339 Key Information - Prestige consumer healthcare inc.
  • TABLE 340 Key Information - WellSpring Pharmaceutical Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Motion Sickness Treatment Market share by Drug Class, 2022
  • FIG 3 Global Motion Sickness Treatment Market share by Drug Class, 2029
  • FIG 4 Global Motion Sickness Treatment Market by Drug Class, 2019 - 2029, USD Million
  • FIG 5 Global Motion Sickness Treatment Market share by Route of Administration, 2022
  • FIG 6 Global Motion Sickness Treatment Market share by Route of Administration, 2029
  • FIG 7 Global Motion Sickness Treatment Market by Route of Administration, 2019 - 2029, USD Million
  • FIG 8 Global Motion Sickness Treatment Market share by Distribution Channel, 2022
  • FIG 9 Global Motion Sickness Treatment Market share by Distribution Channel, 2029
  • FIG 10 Global Motion Sickness Treatment Market by Distribution Channel, 2019 - 2029, USD Million
  • FIG 11 Global Motion Sickness Treatment Market share by Region, 2022
  • FIG 12 Global Motion Sickness Treatment Market share by Region, 2029
  • FIG 13 Global Motion Sickness Treatment Market by Region, 2019 - 2029, USD Million
  • FIG 14 Swot analysis: Abbott laboratories